Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4779522
Max Phase: Preclinical
Molecular Formula: C39H61N5O6S
Molecular Weight: 728.01
Molecule Type: Unknown
Associated Items:
ID: ALA4779522
Max Phase: Preclinical
Molecular Formula: C39H61N5O6S
Molecular Weight: 728.01
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCO[C@H](C[C@H](C(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H]1CCCCN1C)[C@@H](C)CC)c1nc(C(=O)N[C@@H](Cc2ccccc2)C[C@H](C)C(=O)O)cs1
Standard InChI: InChI=1S/C39H61N5O6S/c1-9-20-50-33(37-41-30(24-51-37)35(45)40-29(21-27(6)39(48)49)22-28-16-12-11-13-17-28)23-32(25(3)4)44(8)38(47)34(26(5)10-2)42-36(46)31-18-14-15-19-43(31)7/h11-13,16-17,24-27,29,31-34H,9-10,14-15,18-23H2,1-8H3,(H,40,45)(H,42,46)(H,48,49)/t26-,27-,29+,31+,32+,33+,34-/m0/s1
Standard InChI Key: MDZSDMUTKXZRCX-PUJOPEOLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 728.01 | Molecular Weight (Monoisotopic): 727.4343 | AlogP: 5.95 | #Rotatable Bonds: 20 |
Polar Surface Area: 141.17 | Molecular Species: ACID | HBA: 8 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.21 | CX Basic pKa: 7.09 | CX LogP: 3.48 | CX LogD: 3.12 |
Aromatic Rings: 2 | Heavy Atoms: 51 | QED Weighted: 0.15 | Np Likeness Score: -0.07 |
1. Courter JR,Hamilton JZ,Hendrick NR,Zaval M,Waight AB,Lyon RP,Senter PD,Jeffrey SC,Burke PJ. (2020) Structure-activity relationships of tubulysin analogues., 30 (14): [PMID:32527543] [10.1016/j.bmcl.2020.127241] |
Source(1):